Dr. Angus Worthing Believes the Cost of Rheumatoid Arthritis Medication Should Be a Crime and Is Fighting for Arthritis Patients Rights

Share Article

Dr. Angus Worthing of the Arthritis & Rheumatism Associates, P.C. is fighting for arthritis patients' health, treatment, and medication cost. Authoring the recent article published by The Washington Post "Protecting Access to Medication," Dr. Worthing discusses the rising cost of arthritis medication and the impact on patients financially.

Angus B. Worthing, MD, FACR

Angus B. Worthing, MD, FACR Washington, DC - Chevy Chase, MD

This cost can become especially expensive if you suffer with Rheumatoid Arthritis; excelling up to 5o percent, averaging thousands of dollars per month.

Dr. Angus Worthing of the Arthritis & Rheumatism Associates, P.C. is fighting for arthritis patients' health, treatment, and medication cost. In a recent article published on June 5 by The Washington Post "Protecting Access To Medication," where Dr. Worthing was the contributing author of the piece, he disclosed patients medication cost is exceeding budgets across the Washington, DC district.

Who's to blame and how is the cost impacting patients' health in the long-term? Dr Worthing explains, "Patients are forced to share the high cost of a specialty prescription with their health insurance company — $10 or $20 co-pays for a drug have morphed into co-insurance with the patient paying a percentage of the cost of each prescription. That’s intended to turn people toward generic and other less-expensive medicines, but sometimes a specialty drug is the only one that works". Moreover, this cost can become especially expensive if you suffer with Rheumatoid Arthritis, excelling up to 50 percent, averaging thousands of dollars per month.

Dedicated to his craft of providing outstanding treatment options for arthritis, Dr. Worthing partnered with DC Council member Mary Cheh and Anita Bond to introduce The Specialty Drug Co-payment Limitation Act of 2015. The bill, if passed, would limit the cost of specialty drug co-payments in the Washington, DC District.

The fight for capping cost is spreading in neighboring states, such as Maryland and Delaware, with successful results. Meanwhile the Washington District and Virginia area await their fate. While lawmakers are putting on their thinking caps to pass this over deserving bill, medical officials such as Dr. Angus Worthing continue to stay on the frontline raising a voice for patients and more affordable medication options.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenda Brouillette - Public Relations
@WashDCArthritis
since: 05/2014
Follow >
Arthritis & Rheumatism Associates, PC
since: 06/2013
Like >
Follow us on
Visit website